MDGL stock is up as the company reports better-than-expected third-quarter results, beating earnings and revenue estimates, driven by strong Rezdiffra...

Halozyme reports better-than-expected third-quarter 2024 results. The company raises revenue guidance for 2024. Stock rises in after-hours trading.

FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.

FORM's third-quarter 2024 results benefit from record DRAM probe-card revenues on strong demand. Its weak guidance hurts shares.

General Motors posts better-than-expected results and also lifts its full-year forecast for adjusted EBIT, EPS and FCF.

SNY posts strong third-quarter results, beating estimates for both earnings and sales. Shares rise in pre-market.

ALKS reports weaker-than-expected third-quarter 2024 results. Net sales of proprietary products increase year over year. Shares down.

MRK posts better-than-expected third-quarter results. The company lowers its guidance, likely due to the soft sales performance of the Gardasil...

D's third-quarter earnings are better than expected. It plans to invest $43 billion in the next five years.

Church & Dwight's Q3 results reflect increased sales and earnings on strong consumer demand, resilience of its brands and successful new product...